Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal…
International Athletes’ Forum 2025 empowers and inspires over 400 athlete representatives
12 June 2025 - More than 400 athlete representatives gathered in Lausanne, Switzerland,…
New Sleep Apnea Mouth Guard Over the Counter for 2025 – Latest OTC MouthGuard and Mouthpiece for Sleep Apnea OSA from AirSnore
Glasgow, United Kingdom , June 11, 2025 (GLOBE NEWSWIRE) -- Finding an…
Hisense Tops Global Rankings in Q1 2025 for MiniLED, 100-inch and over, and Laser TVs
QINGDAO, China, June 6, 2025 /PRNewswire/ -- Hisense, a leading brand in…
Bybit donates over $300,000 to support earthquake relief in Myanmar and Thailand
DUBAI, UAE, June 5, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
